Posted by Michael Wonder on 15 Nov 2016
Revising the guideline on first-in-human clinical trials
15 November 2016 - Changes are open for comments until end of February 2017.
The EMA, in cooperation with the European Commission and the Member States of the European Union, is proposing changes to its existing guideline on first-in-human clinical trials, to further improve the safety of trial participants. The revised guideline is open for public consultation until 28 February 2017.
